| Robert Y Chiang, DDS | |
|
1331 Medical Center Dr Ste G, Rohnert Park, CA 94928-2900 | |
| (707) 585-2525 | |
| Not Available |
| Full Name | Robert Y Chiang |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1331 Medical Center Dr Ste G, Rohnert Park, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063699452 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 56029 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert Y Chiang, DDS 1331 Medical Center Dr Ste G, Rohnert Park, CA 94928-2900 Ph: (707) 585-2525 | Robert Y Chiang, DDS 1331 Medical Center Dr Ste G, Rohnert Park, CA 94928-2900 Ph: (707) 585-2525 |
News Archive
In the debate over healthcare reform, the healthcare supply chain has been largely overlooked as an effective way to reduce the cost of healthcare. Yet GHX and a collaborative community of healthcare providers, manufacturers, distributors and group purchasing organizations (GPOs) have already documented more than $1.3 billion in savings, and are on track to cut another $5 billion from the cost of healthcare over the next 5 years.
How do certain multiple myeloma treatment drugs cause complications? How does the immune system become dysfunctional due to cancer? How safe is a vaccine that could prevent development of precancerous colon polyps? Those are among the many questions that will be answered by researchers from the University of Pittsburgh Cancer Institute and the University of Pittsburgh School of Medicine during the American Association for Cancer Research 102nd Annual Meeting 2011, April 2 to 6, in Orlando, Fla.
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.
Laboratory analysis from the first arm of a phase II clinical trial testing the use of nilotinib in patients with Parkinson's disease demonstrates precisely how the agent increases levels of dopamine in the brains of study participants, says a research team at Georgetown University Medical Center. Symptoms of Parkinson's, such as motor dysfunction, are a result of a dopamine loss.
› Verified 1 days ago
Dr. Jamie Jad Sahouria, D.D.S., M.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1303 Medical Center Dr, Rohnert Park, CA 94928 Phone: 707-586-6600 | |
Dr. Philip Allen Terribilini, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1331 Medical Center Dr, Suite G, Rohnert Park, CA 94928 Phone: 707-585-2525 Fax: 707-585-2530 | |
Dr. Sadi N Kermani, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1331 Medical Center Dr Ste F, Rohnert Park, CA 94928 Phone: 707-852-1662 Fax: 707-755-3895 | |
Dr. Thy Nguyen Anh Pham, D.D.S Dentist Medicare: Medicare Enrolled Practice Location: 6315 Commerce Blvd, Rohnert Park, CA 94928 Phone: 707-584-7401 | |
Neelkamal Syal, Dentist Medicare: Not Enrolled in Medicare Practice Location: 6315 Commerce Blvd, Rohnert Park, CA 94928 Phone: 707-584-7401 | |
George Gregory Henley, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 5200 Snyder Ln, Rohnert Park, CA 94928 Phone: 707-584-9589 Fax: 707-584-8057 |